Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PENTOSTATIN for Leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 16 adverse event reports in the FDA FAERS database where PENTOSTATIN was used for Leukaemia.

Most Reported Side Effects for PENTOSTATIN

Side Effect Reports % Deaths Hosp.
Neutropenia 42 9.2% 5 17
Drug ineffective 37 8.1% 2 3
Off label use 32 7.0% 11 4
Bk virus infection 30 6.6% 0 0
Anaemia 28 6.2% 6 10
Dyspnoea 24 5.3% 5 14
Pyrexia 24 5.3% 1 14
Thrombocytopenia 24 5.3% 3 3
Cystitis haemorrhagic 23 5.1% 1 0
Product use in unapproved indication 23 5.1% 4 0
Sepsis 23 5.1% 16 4
Pneumonia 21 4.6% 6 12
Diarrhoea 20 4.4% 8 13
Thrombotic microangiopathy 20 4.4% 3 2
Neutrophil count decreased 19 4.2% 0 7

Other Indications for PENTOSTATIN

Chronic lymphocytic leukaemia (127) Bone marrow conditioning regimen (59) Hairy cell leukaemia (59) Allogenic stem cell transplantation (44) Product used for unknown indication (15) Prophylaxis against graft versus host disease (14) Chronic graft versus host disease (13) T-cell prolymphocytic leukaemia (11) Richter's syndrome (9) Graft versus host disease (8)

Other Drugs Used for Leukaemia

DASATINIB (654) VENETOCLAX (307) CYTARABINE (288) METHOTREXATE (282) IMATINIB (281) RUXOLITINIB (230) NILOTINIB (203) BOSUTINIB (191) VINCRISTINE (172) CYCLOPHOSPHAMIDE (153)

Related Pages

PENTOSTATIN Full Profile All Leukaemia Drugs PENTOSTATIN Demographics PENTOSTATIN Timeline